Which two anticonvulsants are most commonly used for neuropathic pain and what is a key consideration?

• A. Gabapentin and pregabalin; monitor sedation, dizziness, and renal function (adjust dose).
• B. Carbamazepine and oxcarbazepine; monitor hyponatremia.
• C. Lamotrigine and valproate; monitor hepatic enzymes.
• D. Phenytoin and topiramate; monitor cognitive impairment.

Answer: (A)

Gabapentin and pregabalin are the two anticonvulsants most commonly used for neuropathic pain. They are gabapentinoids that bind the alpha2-delta subunit of voltage-gated calcium channels in pain pathways, which reduces the release of excitatory neurotransmitters and dampens abnormal nerve signaling responsible for neuropathic pain, as seen in conditions like diabetic neuropathy and postherpetic neuralgia.

A key practical consideration is renal function. These drugs are primarily excreted by the kidneys, so kidney impairment necessitates dose adjustments to avoid buildup and toxicity. Start with conservative dosing and titrate carefully, with regular renal function monitoring, especially in older patients. Common early adverse effects to watch for are sedation and dizziness, which can limit function and safety, so these should be assessed alongside dose adjustments.

Other anticonvulsants can have issues that make them less ideal for neuropathic pain: for example, carbamazepine and oxcarbazepine carry a notable hyponatremia risk; lamotrigine and valproate require hepatic monitoring; phenytoin and topiramate can cause cognitive effects.